Regulatory updateRetina

Faricimab: start with the current EU product information

EMA · Regulatory sourceEuropean Medicines Agency ↗

Editorial review: not recorded.

Bottom line

The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.

Why read it

Keep drug evidence and jurisdiction-specific product information linked in one place.

What this does not prove

Source checked on 2026-09-17; no new approval is asserted. Consult the current product information for prescribing.

Original source

  1. European Medicines Agency ↗

Source date: 17 Sept 2026 · EU

Report a correction →